A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients.
Clin Infect Dis
; 71(11): 2777-2786, 2020 12 31.
Article
in En
| MEDLINE
| ID: mdl-31793991
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Respiratory Tract Infections
/
Respiratory Syncytial Virus Infections
/
Hematopoietic Stem Cell Transplantation
Type of study:
Clinical_trials
Limits:
Adult
/
Humans
Language:
En
Journal:
Clin Infect Dis
Journal subject:
DOENCAS TRANSMISSIVEIS
Year:
2020
Type:
Article
Affiliation country:
United States